DeutschNewstral
Article
LA Times on 2017-02-16 05:13
UC Berkeley suffers big loss in CRISPR patent fight: What's next?
Related news
UC Berkeley suffers setback in patent battle over CRISPR gene-editing toolSan Jose Mercury News- UC granted a key CRISPR patentSan Jose Mercury News
- NTwelfth CRISPR patent awarded to UC teamnews.berkeley.edu
- DUC obtains 8th patent for CRISPR gene-editing methodsdailycal.org
- NUC now holds largest CRISPR-Cas9 patent portfolionews.berkeley.edu
- NUC files appeal to revive CRISPR patent interferencenews.berkeley.edu
- NUC issued fourth CRISPR patent; three more on the waynews.berkeley.edu
- NUC rings out 2019 with its 20th CRISPR patentnews.berkeley.edu
- NUC defends CRISPR patent rights in Court of Appealsnews.berkeley.edu
- NUC awarded third CRISPR patent, expanding its gene-editing portfolionews.berkeley.edu
- NUC receives its 11th U.S. patent for CRISPR-Cas9news.berkeley.edu
- DUC Berkeley announces patenting of gene-editing technology CRISPRdailycal.org
- NEuropean Patent Office to grant UC a broad patent on CRISPR-Cas9news.berkeley.edu
- DUC Berkeley receives its 4th CRISPR patent, expects 3 more afterdailycal.org
The CRISPR patent battle is back on as UC Berkeley files an appealTechCrunch
UC Berkeley CRISPR Patent Revoked in Europe Due To Invalid Priority Claimjdsupra.com- NUC receives patent for use of CRISPR-Cas9 to tune gene expressionnews.berkeley.edu
- DTeam including UC Berkeley researcher awarded patent on CRISPR-Cas9 use in all cells amid pending appealdailycal.org
- DUC Berkeley, UCSF, British pharmaceutical company to collaborate on CRISPR research labdailycal.org
- DUC files opening brief to appeal CRISPR-Cas9 patent decisiondailycal.org